(Q40816692)

24 September 2017

S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide (English)

1 reference

24 September 2017

0 references

Zeldis JB

1

1 reference

24 September 2017

Williams BA

series ordinal

2

1 reference

24 September 2017

Thomas SD

series ordinal

3

1 reference

24 September 2017

Elsayed ME

series ordinal

4

1 reference

24 September 2017

1 February 1999

1 reference

24 September 2017

Clinical Therapeutics

1 reference

24 September 2017

21

1 reference

24 September 2017

319-330

1 reference

24 September 2017

2

1 reference

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

Thalidomide revisited: pharmacology and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

Die Thalidomid-Embryopathie*

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

When a uniquely effective drug is teratogenic. The case of isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988289-2

7 January 2021

10.1016/S0149-2918(00)88289-2

Identifiers

DOI

1 reference

24 September 2017

1 reference